Novo Nordisk's new CagriSema obesity drug trial to begin on Feb. 10, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.
New Atlas9h
Weight-loss breakthrough as new appetite-curbing hormone is found
A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone ...
Scholar Rock: More Than Just An SMA Biotech With Q2 2025 Obesity Treatment Data
Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for Priority Review to be given. Explore more details here.
Hosted on MSN13h
Where Is Jacky From ‘My 600-Lb Life’ Now? A Look at Her Remarkable Weight-Loss Progress
Jacky Rogers appeared on Season 13 of 'My 600-Lb Life.' Here's where she is now and what she's said about her progress since filming wrapped.
Heavy marijuana use can impact young adults' short-term memory, study suggests
Heavy weed use appears to dull the brains of young adults, particularly affecting their short-term working memory, a new study suggests.
Study links long COVID severity with white blood cell count
Higher levels of leukocytes -- a form of white blood cell -- are associated with more severe symptoms of long COVID among ...
BusinessMirror23h
Make realistic New Year’s resolutions and work to achieve them–expert
It’s time to take your New Year’s resolutions to heart. According to social psychologists, New Year’s resolutions that are too ambitious and not turned into habits are more likely to fail during the ...
Amgen's SWOT analysis: stock outlook amid obesity drug race, pipeline progress
Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a ...